|
|
This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956314.
|
|
|
Title: Novel, Potent and Selective 5-HT2c Receptor Agonists for the Treatment of Neurological Disorders
Date: February 15, 2024 5:00-6:00 PM (Berlin Time, CET) Speaker: Dr. Lynette Nejabet (Abbvie) Venue: online
0 Comments
Check the new ALLODD publication:
Nerín-Fonz F., Cournia Z., 2024 Machine learning approaches in predicting allosteric sites. Curr. Opin. Struct. Biol. https://doi.org/10.1016/j.sbi.2024.102774 |
